A 47-year-old man diagnosed with pulmonary tuberculosis was referred to our hospital. Rifampicin, isoniazid, pyrazinamide and ethambutol were administered, and the patient's symptoms promptly improved. On the 19th hospital day, he developed acute kidney injury with a fever and chills. Renal biopsy specimens indicated tubulointerstitial nephritis. Suspecting rifampicin-induced acute kidney injury, we discontinued the rifampicin and administered levofloxacin in its place. The patient's serum creatinine level subsequently gradually improved. We herein report this case and review eight cases reported in Japan. We found that the rifampicin toxicity appeared at both the initial administration and readministration. All eight patients presented with proteinuria.
Introduction
Rifampicin is a key drug for the treatment of tuberculosis. The morbidity of tuberculosis is increasing, especially in developing countries. The prevalence of tuberculosis as a reemergent infectious disease is significant in Japan. Rifampicin often elicits a hepatotoxic response and gastroenteropathy. Although relatively uncommon, cases of rifampicininduced acute kidney injury have been reported. A severe response to rifampicin typically occurs when the drug is readministered. Rifampicin-induced acute kidney injury usually has a favorable course with treatment; a full recovery of the renal function is reportedly achieved in 40% and 96% of patients at 30 and 90 days from onset, respectively (1) . We herein report a case of acute kidney injury occurring during the initial treatment for tuberculosis with rifampicin and other agents. We describe the details of the case and review the literature from Japan.
Case Report
A 47-year-old man presented to a clinic with a productive cough and fever. The condition had persisted for approximately one month. Within that time, the patient's body weight had dropped by 5 kg. He had no significant medical history. A chest radiograph showed infiltration and cavities in the bilateral upper lung fields. A sputum smear was positive for acid-fast bacilli, and polymerase chain reaction for Mycobacterium tuberculosis was positive. The patient was diagnosed with pulmonary tuberculosis and referred to our hospital for inpatient treatment. On a physical examination, he had a body temperature of 39.2 , a blood pressure of 107/65 mmHg, a pulse of 110 beats per minute and an oxygen saturation of 95% on room air. His lungs were clear on auscultation. The laboratory findings indicated inflammation (white blood cell count: 14,200 cells/μL, neutrophils: 89%, eosinophils: 0%, C-reactive protein: 11.75 mg/dL) and slightly elevated hepatobiliary enzymes (aspartate amino transferase: 41 U/L, alanine transaminase: 52 U/L, alkaline phosphatase: 586 U/L, γ-glutamyltransferase: 207 U/L). A urinalysis showed proteinuria, urinary sugar at a weakly positive level, hyaline casts, epithelial casts and granular casts. A chest radiograph demonstrated infiltration around the cavities in the bilateral upper lung fields, blunting of the right costophrenic angle and diaphragm elevation (Fig. 1) . Computed tomography scanning of the chest revealed centrilobular particulate opacity and cavities in the bilateral lung fields with slight pleural effusion in the right lung (Fig. 2) . The patient was given a daily regimen of rifampicin (450 mg), isoniazid (300 mg), pyrazinamide (1.2 g) and ethambutol (750 mg). The patient's symptoms initially improved following the initiation of treatment; however, on the 19th day, he developed a high fever with chills. At the same time, the laboratory findings showed kidney failure with mild anemia and hepatic injury. The levels of N-acetyl-β-Dglucosaminidase and β2-microglobulin in the urine were markedly increased (31.1 U/L and 42,114 μg/L, respectively). The uric protein level was 1.4 g/day, and no Bence Jones proteinuria was detected. Acid-fast bacteria staining and urine cultures were negative. Suspecting drug-induced kidney injury, we decided to suspend the administration of all antituberculous drugs on the 28th hospital day. The patient's serum creatinine level continued to rise in the ensuing weeks without drug treatment, until peaking at 3.87 mg/ dL on the 53rd hospital day (Fig. 3) . Specimens from a renal biopsy performed on the 49th hospital day indicated tubulointerstitial nephritis (Fig. 4) . Plasma cells, neutrophils, lymphocytes and slight eosinophil infiltration were observed in the interstitium. Neither caseating epithelioid cell granuloma nor acid-fast bacteria were observed. Rifampicininduced acute kidney injury was suspected as the most likely diagnosis. Ethambutol (500 mg), pyrazinamide (1 g), alternate-day administration of levofloxacin (400 mg) and isoniazid (300 mg) were administered in sequence. The drug doses were adjusted according to the degree of renal dys- function. The patient's serum creatinine level gradually decreased, ultimately reaching an almost normal level (1.11 mg/dL) at the end of the 18 months of treatment.
Discussion
Kidney diseases associated with tuberculosis include direct infection of the urinary tract with Mycobacterium tuberculosis, secondary amyloidosis, drug-induced nephrotoxicity and tuberculosis interstitial nephritis (2) . In the present case, acute kidney injury appeared during the administration of antituberculous drugs and slowly improved after the drugs were discontinued. This clinical course implicated the antituberculous drugs as the cause of the patient's acute kidney injury. The pathological findings of the renal biopsy specimen were also consistent with the pathogenesis of druginduced nephrotoxicity. A few reports have described kidney injury induced by isoniazid (3), ethambutol (4) and pyrazinamide (5, 6) . The readministration of these drugs, not including rifampicin, did not worse the patient's renal function; therefore, we considered that the acute kidney disease observed in this case was due to rifampicin. Rifampicininduced acute kidney injury is often accompanied by anemia, thrombocytopenia and hepatic injury (1). Our patient also had mild anemia and hepatic injury. Since the first account from Poole et al. in 1971 (7), almost 150 reports of rifampicin-induced acute kidney injury have been documented. According to an analysis by Covic et al., the largest analysis completed thus far, there has been one review of 170 consecutive patients with acute kidney injury following the readministration of rifampicin in Romania (8); however, there have been few reviews from East Asia. Therefore, we reviewed eight reported cases of rifampicin-induced acute kidney injury occurring during treatment for Mycobacterium tuberculosis or Mycobacterium kansasii in Japan (Table) (9) (10) (11) (12) (13) (14) (15) (16) . Distinctions have been drawn between two types of administration, the initial administration and readministration, and between two types of regimens, continuous and intermittent. Rifampicin-induced acute kidney injury typically appears in patients who have received readministration or an intermittent regimen (1, 7, 8) , although it also appears in some patients treated with initial or continuous administration (17) . Similarly, in our review of eight cases reported in Japan, three patients (38%) received initial and continuous administration, and the remaining five patients (62%) received readministration. The mean period from the initial administration or readministration of rifampicin to disease onset was 16.4±10.2 days. In addition, anti-rifampicin antibodies have been detected in some cases (17) . In our review, antibodies were tested in six cases and found to be positive in four cases. Fever and chills were the most common symptoms (75%) in the Japanese patients, as well as the patients reported overseas. Additionally, all of the patients in our review had proteinuria. Three patients (38%) with proteinuria (a protein level of >3.5 g/day) eventually developed edema, a symptom not emphasized in overseas reports (1, 17) . The mean maximum serum creatinine level for all cases was 7.46 mg/dL. The serum creatinine levels were higher in the patients requiring dialysis (10.55 mg/dL) than in the patients not requiring dialysis (4.37 mg/dL). Tubulointerstitial lesions were commonly seen in the histopathology of the kidney biopsy specimens (63%). Glomerular lesions were observed in two cases (25%). In addition to requiring rifampicin cessation, four patients (50%) with oliguria required dialysis, and two patients (25%) with proteinuria (a protein level of >3.5 g/day) received corticosteroids.
With treatment, the clinical course of rifampicin-induced acute kidney injury is considered favorable in most patients. Covic et al. found one death among 60 patients with postrifampicin acute renal failure, which was attributed to generalized extension of tuberculosis (1). Our patient improved once rifampicin was discontinued, and no dialysis was required. His proteinuria and slight urinary sugar of unknown etiology was already present on admission, and a latent renal disease, such as diabetic nephropathy, could have delayed the improvement of renal dysfunction. Even so, the kidney biopsy specimen showed no signs of an underlying chronic disorder. The serum creatinine level remained outside of the normal range for a period of 90 days. We debated whether to use corticosteroids but eventually concluded that the benefits of corticosteroids for acute interstitial nephritis were too inconclusive to merit treatment. A retrospective study examined the effects of steroids on the recovery of the renal function in 52 patients with druginduced acute interstitial nephritis compared to that observed in nine untreated patients with acute interstitial nephritis. The significant benefits observed with steroids included a lower rate of the need for dialysis by 18 months (4% vs. 44%) and lower serum creatinine levels [2.1 vs. 3.7 mg/ dL (18) ]. On the other hand, another retrospective study of 42 cases of acute interstitial nephritis demonstrated no benefits from glucocorticoid therapy. In that study, 26 patients were treated with intravenous methylprednisolone for three days followed by oral prednisone; the remaining 16 patients were not treated. There were no differences in the serum creatinine levels between the two groups at one, six and 12 months [at one year, the mean serum creatinine level was 1.60 mg/dL in both groups (19) ].
We herein reported a case of rifampicin-induced acute kidney injury emerging during a course of tuberculosis treatment. This condition can be induced not only by readministration, but also by the initial administration. Kidney biopsies may reveal either tubulointerstitial or glomerular lesions. Edema resulting from proteinuria is also relatively common in Japanese cases.
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